Original ResearchPublished 9 October 2026Cytarabine-based mobilisation yields higher CD34+ cell counts than cyclophosphamide regardless of prior daratumumab exposure in multiple myelomaWojciech Szlasa · Artur Borkowski · Monika Mordak-Domagała · Jacek Kwiatkowski · Katarzyna Malesa · Mateusz Sawicki · Jarosław DybkoFrontiers in Oncologydoi 10.3389/fonc.2026.1915658
Case ReportPublished 23 January 2026Daratumumab in severe Evans syndrome: a case reportStefan M. Hillmann · Hendrik Brockhoff · Sarah Loebel · Suna Hentschke · Dirk Arnold · Hans SalwenderFrontiers in Hematologydoi 10.3389/frhem.2025.1719208